| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001989695 |
| P356 | DOI | 10.1038/SJ.BJC.6600180 |
| P932 | PMC publication ID | 2364143 |
| P698 | PubMed publication ID | 11953826 |
| P5875 | ResearchGate publication ID | 11412992 |
| P2093 | author name string | D Walker | |
| R Perry | |||
| M Carter | |||
| V Balaji | |||
| J Nicholson | |||
| D W Ellison | |||
| F Ross | |||
| J Crolla | |||
| R Allibone | |||
| R Gilbertson | |||
| P2860 | cites work | Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas | Q24671002 |
| Lack of histopathological correlation of malignant ependymomas with postoperative survival | Q30461214 | ||
| Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. | Q32073310 | ||
| Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group | Q32076979 | ||
| Karyotype studies in 18 ependymomas with literature review of 107 cases | Q33718650 | ||
| Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma | Q33871385 | ||
| Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma | Q34085362 | ||
| Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas | Q34404481 | ||
| Molecular cytogenetic studies of pediatric ependymomas | Q34462444 | ||
| Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups | Q35746432 | ||
| Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization | Q35765248 | ||
| Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours | Q36620330 | ||
| Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation | Q38462467 | ||
| Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors | Q39370472 | ||
| Fourth ventricle ependymomas. A study of 20 cases with survival analysis. | Q40502175 | ||
| The molecular biology of ependymomas | Q40898736 | ||
| Comparative genomic hybridization in hypotriploid/hyperdiploid tumors. | Q41086305 | ||
| The prognostic significance of postoperative residual tumor in ependymoma | Q41152933 | ||
| A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors | Q41671329 | ||
| Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979. The Childhood Brain Tumor Consortium | Q43668915 | ||
| Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas | Q43960135 | ||
| Histologic prognostic factors in ependymoma | Q44250867 | ||
| Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. | Q44452897 | ||
| PTEN mutations in gliomas and glioneuronal tumors. | Q47995275 | ||
| Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960-1984. | Q48401371 | ||
| Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors | Q48548283 | ||
| Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy | Q48563077 | ||
| Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. | Q48566471 | ||
| Infratentorial ependymomas in childhood: prognostic factors and treatment | Q49077649 | ||
| Multiple primary intracranial tumors in von Recklinghausen's neurofibromatosis. | Q51236250 | ||
| Cytogenetic abnormalities in human ependymomas. | Q53512892 | ||
| Prognostic factors in childhood ependymomas. | Q55053967 | ||
| Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas. | Q55474890 | ||
| Ependymomas in children. | Q55475088 | ||
| Prognostic factors in intracranial ependymomas in children. | Q55475092 | ||
| Cytogenetic study of 33 ependymomas. | Q55476342 | ||
| Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. | Q55479537 | ||
| Intracranial ependymomas of childhood: long-term outcome and prognostic factors. | Q55480395 | ||
| Cytogenetic analysis of 109 pediatric central nervous system tumors. | Q55482615 | ||
| Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. | Q55487073 | ||
| Molecular genetic analysis of non-astrocytic gliomas | Q77410316 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 929-939 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Genetic abnormalities detected in ependymomas by comparative genomic hybridisation | |
| P478 | volume | 86 |
| Q36136815 | A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. |
| Q55472227 | Aberrant CpG island methylation of multiple genes in ependymal tumors. |
| Q36106882 | Advances in the treatment of pediatric brain tumors. |
| Q24658389 | Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective |
| Q48136404 | CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours |
| Q92446433 | Case-based review: ependymomas in adults |
| Q38003799 | Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas |
| Q55470168 | Chromosomal imbalances in clear cell ependymomas. |
| Q37196135 | Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma |
| Q34943656 | Classification and controversies in pathology of ependymomas |
| Q48152949 | Clear cell ependymoma: A clinicopathologic and radiographic analysis of 10 patients |
| Q35805725 | Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence |
| Q34132926 | Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma |
| Q34166553 | Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors |
| Q36560149 | Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. |
| Q38083798 | Emerging insights into the ependymoma epigenome |
| Q40150706 | Evaluation of chromosome 1q gain in intracranial ependymomas. |
| Q38509851 | Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis |
| Q42129591 | Gene Expression Patterns in Ependymomas Correlate with Tumor Location, Grade, and Patient Age |
| Q35748208 | Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups |
| Q39459076 | Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system |
| Q35053098 | Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts |
| Q38653412 | Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome |
| Q33990951 | Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease |
| Q33803137 | Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification |
| Q55472289 | Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: a paradox? |
| Q24652909 | Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma |
| Q48508725 | Late spinal cord metastasis of fourth ventricle ependymoma appeared nineteen years after the initial treatment |
| Q48895739 | Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray |
| Q56673183 | Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3 |
| Q24683906 | Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3 |
| Q36461766 | Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups |
| Q30438459 | Molecular genetics of ependymoma |
| Q57652291 | Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas |
| Q37427424 | Molecular neuropathology of gliomas |
| Q37350207 | Molecular profiling of pediatric brain tumors: insight into biology and treatment |
| Q43662312 | Nestin expression identifies ependymoma patients with poor outcome |
| Q36902043 | Pediatric CNS tumors: current treatment and future directions. |
| Q38616800 | Pediatric Ependymoma |
| Q38035070 | Pediatric neuro-oncology: current status and future directions. |
| Q36344765 | Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis |
| Q35996275 | Prognosis-related molecular markers in pediatric central nervous system tumors |
| Q54353008 | RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients. |
| Q34802431 | Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13. |
| Q37727557 | Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases. |
| Q48421918 | Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade |
| Q55472537 | Structural genomic abnormalities of chromosomes 9 and 18 in myxopapillary ependymomas. |
| Q44949318 | Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas |
| Q39316156 | Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas. |
| Q34977333 | Survival following treatment for intracranial ependymoma: a review |
| Q37553466 | The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants |
| Q37523394 | The genetic and epigenetic basis of ependymoma. |
| Q34982293 | The history of ependymoma management. |
| Q35945392 | Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma |
| Q38681915 | Understanding Ependymoma Oncogenesis: an Update on Recent Molecular Advances and Current Perspectives |
Search more.